STA-5312 Administered on Alternate Weekdays Every Two Weeks to Patients With Hematologic Malignancies and Patients With Solid Tumors

ClinicalTrials.gov ID: NCT00088101

Public ClinicalTrials.gov record NCT00088101. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 24, 2026, 1:18 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase I Trial of STA-5312 Administered on Alternate Weekdays Every Two Weeks to Patients With Hematological Malignancies and Patients With Solid Tumors

Study identification

NCT ID: NCT00088101
Recruitment status: Completed
Study type: Interventional
Phase: Phase 1
Lead sponsor: Synta Pharmaceuticals Corp.; Industry
Enrollment: 42 participants

Conditions and interventions

Conditions

Interventions

STA-5312 Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jan 31, 2004
Primary completion: Not listed
Completion: Nov 30, 2004
Last update posted: Dec 3, 2008

2004

United States locations

U.S. sites: 8
U.S. states: 7
U.S. cities: 8

Facility	City	State	ZIP	Site status
Wilshire Oncology Medical Group	Pomona	California	91767	—
Baptist Cancer Institute	Jacksonville	Florida	32207	—
University of Chicago	Chicago	Illinois	60637	—
Tufts New England Medical Center	Boston	Massachusetts	02111	—
Newark Beth Israel Medical Center	Newark	New Jersey	—	—
Carolinas HealthCare System	Charlotte	North Carolina	28203	—
The West Clinic	Memphis	Tennessee	38120	—
The Sarah Cannon Cancer Center	Nashville	Tennessee	37203	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00088101, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Dec 3, 2008 · Synced Jul 24, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00088101 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →